Mark Lupher

4.0k total citations · 1 hit paper
38 papers, 3.4k citations indexed

About

Mark Lupher is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Lupher has authored 38 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Lupher's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Biomarkers in Disease Mechanisms (5 papers). Mark Lupher is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Biomarkers in Disease Mechanisms (5 papers). Mark Lupher collaborates with scholars based in United States, Australia and Japan. Mark Lupher's co-authors include Hamid Band, Jeremy S. Duffield, Sachiko Miyake, Victor J. Thannickal, Thomas A. Wynn, Brian Druker, Navin Rao, Brian T. Nowlin, Shuei‐Liong Lin and Ana P. Castaño and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Mark Lupher

35 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Host Responses in Tissue Repair and Fibrosis

2012 497 citations Jeremy S. Duffield, Mark Lupher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Lupher United States	27	1.6k	1.3k	596	388	377	38	3.4k
Dianne Sako United States	21	1.4k 0.9×	816 0.6×	457 0.8×	955 2.5×	288 0.8×	32	3.2k
Mina Fogel Israel	31	2.1k 1.4×	853 0.7×	1.3k 2.1×	464 1.2×	322 0.9×	62	3.9k
C H Heldin Sweden	24	1.6k 1.1×	573 0.4×	553 0.9×	373 1.0×	234 0.6×	26	3.0k
Philip D. King United States	34	1.5k 0.9×	1.4k 1.1×	1.1k 1.9×	269 0.7×	118 0.3×	76	3.5k
Alec M. Cheng United States	25	1.7k 1.1×	2.0k 1.5×	545 0.9×	339 0.9×	96 0.3×	28	3.9k
M. Nicotra Italy	26	1.1k 0.7×	1.1k 0.8×	785 1.3×	689 1.8×	246 0.7×	70	3.0k
Lars H. Engelholm Denmark	31	1.3k 0.8×	571 0.4×	1.1k 1.8×	730 1.9×	264 0.7×	79	3.4k
Mario N. Lioubin United States	23	2.1k 1.3×	752 0.6×	879 1.5×	322 0.8×	143 0.4×	29	3.1k
Shulamit Katzav Israel	30	2.1k 1.4×	1.3k 1.0×	940 1.6×	416 1.1×	95 0.3×	73	3.8k
Paola Spessotto Italy	31	1.1k 0.7×	502 0.4×	734 1.2×	482 1.2×	255 0.7×	85	2.6k

Countries citing papers authored by Mark Lupher

Since Specialization

Citations

This map shows the geographic impact of Mark Lupher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lupher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lupher more than expected).

Fields of papers citing papers by Mark Lupher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lupher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lupher. The network helps show where Mark Lupher may publish in the future.

Co-authorship network of co-authors of Mark Lupher

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lupher. A scholar is included among the top collaborators of Mark Lupher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lupher. Mark Lupher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Abigail, Cristina L. Abrahams, Millicent Embry, et al.. (2017). High Frequency of CD74 Expression in B-Cell Non-Hodgkin's Lymphoma (NHL) and Targeting with SΤRO-001, a Novel Anti-CD74 Antibody Drug Conjugate (ADC) with Potent I n Vitro Cytotoxicty and In Vivo Anti-Tumor Activity. Blood. 130. 573–573. 1 indexed citations

Embry, Millicent, Xiaofan Li, Abigail Yu, et al.. (2017). CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, SΤRO-001. Blood. 130. 4420–4420. 1 indexed citations

Nakagawa, Naoki, Luke Barron, Ivan G. Gomez, et al.. (2016). Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease. JCI Insight. 1(20). e87446–e87446. 52 indexed citations

Blink, Bernt van den, Matthijs Moerland, Marloes G. J. van Dongen, et al.. (2013). Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 26(6). 672–676. 86 indexed citations

Duffield, Jeremy S. & Mark Lupher. (2010). PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis. Drug News & Perspectives. 23(5). 305–305. 67 indexed citations

Lupher, Mark & W. Michael Gallatin. (2006). Regulation of Fibrosis by the Immune System. Advances in immunology. 89. 245–288. 78 indexed citations

Staunton, Donald E., Mark Lupher, Robert Liddington, & W. Michael Gallatin. (2006). Targeting Integrin Structure and Function in Disease. Advances in immunology. 91. 111–157. 28 indexed citations

Bhattacharya, Ananyo A., Mark Lupher, Donald E. Staunton, & Robert Liddington. (2004). Crystal Structure of the A Domain from Complement Factor B Reveals an Integrin-like Open Conformation. Structure. 12(3). 371–378. 35 indexed citations

Lupher, Mark, et al.. (2001). Cellular Activation of Leukocyte Function-Associated Antigen-1 and Its Affinity Are Regulated at the I Domain Allosteric Site. The Journal of Immunology. 167(3). 1431–1439. 51 indexed citations

10.

Rao, Navin, Mark Lupher, Satoshi Ota, et al.. (2000). The Linker Phosphorylation Site Tyr292 Mediates the Negative Regulatory Effect of Cbl on ZAP-70 in T Cells. The Journal of Immunology. 164(9). 4616–4626. 90 indexed citations

11.

Ota, Satoshi, Kaoru Hazeki, Navin Rao, et al.. (2000). The RING Finger Domain of Cbl Is Essential for Negative Regulation of the Syk Tyrosine Kinase. Journal of Biological Chemistry. 275(1). 414–422. 84 indexed citations

12.

Lill, Nancy L., Patrice Douillard, Rana Awwad, et al.. (2000). The Evolutionarily Conserved N-terminal Region of Cbl Is Sufficient to Enhance Down-regulation of the Epidermal Growth Factor Receptor. Journal of Biological Chemistry. 275(1). 367–377. 120 indexed citations

13.

Fournier, Tanya M., Louie Lamorte, Christiane R. Maroun, et al.. (2000). Cbl-transforming Variants Trigger a Cascade of Molecular Alterations That Lead to Epithelial Mesenchymal Conversion. Molecular Biology of the Cell. 11(10). 3397–3410. 30 indexed citations

14.

Andoniou, Christopher E., Nancy L. Lill, Christine B.F. Thien, et al.. (2000). The Cbl Proto-Oncogene Product Negatively Regulates the Src-Family Tyrosine Kinase Fyn by Enhancing Its Degradation. Molecular and Cellular Biology. 20(3). 851–867. 105 indexed citations

15.

Chen, Andy I., Alexander J. McAdam, Janet E. Buhlmann, et al.. (1999). Ox40-Ligand Has a Critical Costimulatory Role in Dendritic Cell:T Cell Interactions. Immunity. 11(6). 689–698. 254 indexed citations

16.

Lupher, Mark, Navin Rao, Michael J. Eck, & Hamid Band. (1999). The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction. Immunology Today. 20(8). 375–382. 125 indexed citations

17.

Lupher, Mark, Navin Rao, Nancy L. Lill, et al.. (1998). Cbl-mediated Negative Regulation of the Syk Tyrosine Kinase. Journal of Biological Chemistry. 273(52). 35273–35281. 153 indexed citations

18.

Miyake, Sachiko, Mark Lupher, Christopher E. Andoniou, et al.. (1997). The Cbl Protooncogene Product: From an Enigmatic Oncogene to Center Stage of Signal Transduction. Critical Reviews™ in Oncogenesis. 8(2-3). 189–218. 84 indexed citations

19.

Lupher, Mark, Zhou Songyang, Steven E. Shoelson, Lewis C. Cantley, & Hamid Band. (1997). The Cbl Phosphotyrosine-binding Domain Selects a D(N/D)XpY Motif and Binds to the Tyr292Negative Regulatory Phosphorylation Site of ZAP-70. Journal of Biological Chemistry. 272(52). 33140–33144. 183 indexed citations

20.

Lupher, Mark, Kris A. Reedquist, Sachiko Miyake, Wallace Y. Langdon, & Hamid Band. (1996). A Novel Phosphotyrosine-binding Domain in the N-terminal Transforming Region of Cbl Interacts Directly and Selectively with ZAP-70 in T Cells. Journal of Biological Chemistry. 271(39). 24063–24068. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact